Pre-market summary on your portfolio: Delacrox

See the latest news & analysis on your portfolio...

Pre-market Portfolio Digest

* As of Wed, Jul 24, 2024 07:54 ET

Portfolio Health Check

Score Your rating score is 3.27 / 5.0	Breakdown Strong Buy: 1 stock Buy: 2 stocks Hold: 22 stocks Sell: 1 stock Strong Sell: 0 stocks

See full portfolio health check » 

Yesterday's Performance

Top Gainers

HE: +9.79%

HWM: +2.69%

RTX: +1.16%

Top Losers

PSX: -2.17%

D: -2.08%

DE: -2.04%

Top Gainers	Top Losers
HE: +9.79%	PSX: -2.17%
HWM: +2.69%	D: -2.08%
RTX: +1.16%	DE: -2.04%

See all of your holdings » 

Breaking News

	AT&T in charts: Total mobility subscribers, ARPU, net adds show steady growth in Q2 SA News • T
	Pfizer/ Sangamo gene therapy for hemophilia A succeeds in late-stage trial SA News • PFE
	Earnings Summary: AT&T reports mixed Q2 results, reiterates FY2024 guidance SA News • T
	AT&T Non-GAAP EPS of $0.57 in-line, revenue of $29.8B misses by $180M SA News • T
	Collins Aerospace relocating Singapore plant to new $250M manufacturing facility SA News • RTX
	Avangrid Non-GAAP EPS of $0.49 beats by $0.11, revenue of $1.92B beats by $220M SA News • AGR
	The Coca-Cola company announces retirements of 3 directors SA News • KO
	IBM's software growth, Gen AI bookings and consulting growth in focus during Q2 earnings SA News • IBM
	Nielsen winners include Coca-Cola, Celsius Holdings, and Anheuser-Busch InBev SA News • KO
	Viiv's Dovato as effective as Gilead' Biktarvy for HIV but with less weight gain SA News • PFE

See all news on your portfolio »

FEATURED: Be a better investor with Premium

Research shows that individual investors collectively underperform the market, because their decisions are often driven by emotions. Stay ahead of the curve with Seeking Alpha Premium's in-depth analysis and data-driven stock ratings.

Go Premium now »

Analysis

	Coca-Cola Q2: A Cornerstone For Income Accounts Envision Research • KO
	The Coca-Cola Company (KO) Q2 2024 Earnings Call Transcript SA Transcripts • KO
	4 Positives For Johnson & Johnson Manika Premsingh • JNJ

See all analysis on your portfolio »

Related Analysis

	Verizon: Ignore The Noise, Buy The Dip The Asian Investor • T
	Sangamo Therapeutics: A Bust Or Billion Dollar Valuation In The Remaking Pivotal Biotech • PFE
	Wall Street Lunch: Ether ETFs Arrive Wall Street Breakfast • KO
	Energy Transfer: A Gem We Uncovered Outside Our Regular Lane, Too Good To Pass Up Howard Jay Klein • XOM
	Verizon: The Market Is Missing The Forest For The Trees Vladimir Dimitrov, CFA • T
	Clearwater Paper: An Impressive Transformation At A Solid Price The Value Investor • PG
	Voya Corporate Leaders 100 Strategy Q2 2024 Commentary Voya Investment Management • MMM
	FUTY: Utilities Dashboard For July Fred Piard • DUK • D

Download the Seeking Alpha App!

Want More Investing Ideas Newsletters?

Get the Newest Stock Ideas → Stock Ideas

Popular ETF Ideas → ETF Ideas

Stock Ideas for Dividend Investors → Dividends Ideas

Click here to manage notifications for all your portfolios.

This email was sent to you because you signed up to receive Pre-Market Portfolio Digest. If you do not want to receive Delacrox Portfolio Digest emails, click here to unsubscribe.

Sent by Seeking Alpha, 234 5th Avenue, 5th floor, New York, NY 10001

If you believe this has been sent to you in error, please safely unsubscribe.